Previous experiments have identified E4F, an inducible cellular factor that binds to sequences in the adenovirus E4 promoter that are critical for E1A-dependent transcriptional activation. The E4F factor has been purified and shown to stimulate transcription in vitro from the E4 promoter. Analysis of the affinity-purified factor identifies a single polypeptide of 50 kD that has E4F-specific binding activity. E4F binding activity is also regulated during F9 cell differentiation and can be activated in differentiated F9 cells by viral infection. Furthermore, the activation process appears to involve a phosphorylation event, because treatment of E4F with alkaline phosphatase abolishes activity and incubation of the phosphatase-inactivated factor with an extract from virus infected cells restores activity.
In many instances, groups of genes rather than a single gene are controlled through the action of a particular regulatory activity. Thus, in addition to the basic principles and mechanisms by which transcription initiation is regulated, an elucidation of the mechanisms whereby groups of unlinked genes are regulated coordinately is crucial to the final understanding of gene control and the control of cell phenotype. The set of genes controlled by the adenovirus E1A protein is such a system for probing the basis of coordinate gene control (Berk 1986; Nevins 1987) . The E1A protein itself is not a DNA-binding protein (Ferguson et al. 1985) , and it also appears certain that a single cellular transcription factor cannot account for the control. For instance, transcriptional activation of the E2 gene appears to involve a cellular factor termed E2F (Kovesdi et al. 1986; Reichel et al. 1987 Reichel et al. , 1988 , activation of the E1B gene and the hsp70 gene likely depends on activation of a specific TATA factor (Wu et al. 1987; Simon et al. 1988) , and stimulation of class III genes is mediated through the TFIIIC factor (Berger and Folk 1985; Gaynor et al. 1985; Hoeffler and Roeder 1985; Yoshinaga et al. 1986 ). In addition, a cellular factor termed E4F appears to be involved in the activation of E4 transcription (Raychaudhuri et al. 1987) . E4F binds to sequences in the E4 promoter that are important for E1A-induced E4 transcription and can confer E1A inducibility to a heterologous promoter (Gilardi and Perricaudet 1984; Raychaudhuri et al. 1987) . Furthermore, E4F levels, as measured in DNA binding assays, are low in uninfected cells but then rise upon viral infection, dependent on E1A gene expression, and at a time coincident with the rise in E4 transcription (Nevins et al. 1979; Nevins 1981; Raychaudhuri et al. 1987) .
Given the multiplicity of transcription factors apparently involved in the E1A-dependent activation process, there must be some common basis for coordinate control. To approach this question, we have purified the E4F factor and studied the properties of this factor that determine its activity. We find that E4F DNA-binding activity can be modulated by altering the phosphorylation status of the protein in vitro, and an inactive E4F can be activated by an extract from Ad5-infected cells, apparently the result of a specific phosphorylation.
Results

Purification of E4F
E4F was purified from whole-cell extracts of Ad5-infected HeLa cells (as detailed in Materials and methods) with chromatography on heparin agarose, DEAE-Sephadex, and CM-Sepharose. The partially purified E4F preparation then was applied to a DNA-affinity column bearing a polymerized oligonucleotide containing the E4F binding site. The majority of the protein either did not bind to the column or was eluted with a 0.4 M KC1 wash, whereas the active E4F was then eluted with 0.7 M KC1 (Fig. 1A) . As shown in Figure 1B , DNase footprint analysis of the DNA-binding specificity of the affinitypurified material demonstrated that the purified factor recognized the two previously identified E4F binding sites in the E4 promoter localized at -46 to -53 and -163 to -170 (Raychaudhuri et al. 1987) . There was no DNA-binding activity of E4F evidence of protection of a related site located at -140 to which the ATF factor binds , consistent with our previous analysis of E4F binding specificity in whole-cell extracts (Raychaudhuri et al. 1987) . The major polypeptide in the affinity-purified E4F preparation was a protein of 50,000 m.w. when analyzed by SDS gel electrophoresis and silver staining (Fig. 1C) . That this polypeptide indeed possessed the E4F binding activity was demonstrated by eluting various regions of an SDS gel in which an E4F preparation was fractionated, renaturing the proteins, and then assaying each fraction for E4F binding activity by a gel retardation assay. As shown in Figure 1D , the only region of the gel that had renaturable E4F binding activity, as judged by the mobility of the complex in the gel, was that at 50 kD. From this result, as well as the silver stain analysis of the purified E4F preparation, we conclude that the E4F DNA-binding activity is very likely a single poly- peptide of 50 kD. The yield of E4F from 25 grams of HeLa cells was approximately 150 ng, as estimated from the silver-stained gel in comparison to known amounts of molecular weight markers, suggesting the presence of a few thousand molecules of active factor per cell. The fact that there is a close correlation between the kinetics of induction of E4F activity (Raychaudhuri et al. 1987 ) and the kinetics of transcription of the E4 gene in vivo (Nevins et al. 1979) suggests that E4F may be responsible for the E1A-dependent activation of E4 transcription and implies that E4F is a transcription factor. This possibility was tested by assaying aliquots of the fractions eluting from their affinity column for their ability specifically to stimulate E4 transcription in vitro. As shown in Figure 2 , those fractions containing E4F binding activity were also capable of stimulating E4 transcription in vitro whereas these same fractions did not stimulate transcription of the major late promoter. We conclude that the affinity-purified E4F factor is indeed a positive-acting transcription factor, with specificity for the E4 promoter, and that this activity is likely contained in a 50-kD polypeptide that specifically interacts with two sites in the E4 promoter.
E4F is coregulated with E2F during F9 cell differentiation
We previously have identified a cellular factor termed E2F that interacts with two sites in the E2 promoter that are essential for E1A-dependent trans_activation {Ko-vesdi et al. 1986 {Ko-vesdi et al. , 1987 Yee et al. 19891 . Furthermore, the DNA-binding activity of both E2F and E4F is activated in a lyric virus infection dependent on E1A action (Kovesdi et al. 1986; Raychaudhuri et al. 1987} . Our previous experiments have shown that E2F activity is also regulated during differentiation of mouse F9 teratocarcinoma cells (Reichel et al. 1987) , consistent with the presence and regulation of a cellular activity similar to the viral E1A (Imperiale et al. 1984} . E4F binding activity appears to be regulated in a similar manner. Extracts of F9 cells were found to contain substantial levels of E4F activity, independent of a viral infection, whereas E4F activity could not be detected in extracts of the differentiated cells {Fig. 3, left panel}. The specificity of the complex was indicated by the efficient competition of the interaction with an oligonueleotide containing the E4F binding site {Fig. Whole-cell extracts from F9 cells, differentiated F9 cells, and virus-(d1312 or WT) infected differentiated F9 cells were prepared following the procedure described for preparation of HeLa cell extracts (Raychaudhuri et al. 1987) . The extracts were fractionated by heparin-agarose chromatography and after a 0.1 M KC1 wash, columnbound proteins were eluted with buffer containing 0.5 M KC1. Proteins from the 0.5 M elutions were analyzed for E4F activity as described in Fig. 1 . For F9 and dF9 assays, 2.5 ~g of proteins were assayed and for virus-infected (d1312 or WT) dF9 extracts, 12 ~g of proteins were assayed. Virus infections were at 5000 particles/cell for 10 hr. Where indicated, 30 ng of a double-stranded E4F binding oligonucleotide (-43 to -54 of the E4 promoter)was included in the reaction mixes: (lane -)without specific competitor; (lane +) with specific competitor.
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loss of E4F activity upon differentiation apparently was not due to complete loss of the protein, because adenovirus infection of differentiated F9 cells, which thus provides viral E1A function, induced the reappearance of E4F activity (Fig. 3, right panel) . Thus, two factors that are activated during an adenovirus infection of HeLa cells are also coregulated by cellular events during differentiation of teratocarcinoma cells.
E4F activity is controlled by phosphorylation
We have shown that the activation of the E2F factor, as takes place in virus-infected cells, is a post-translational event (Reichel et al. 1988) . Using cell-free extracts, we also have demonstrated that E2F can be activated in vitro using a partially purified extract from virus-infected cells, and that this activation involves a phosphorylation reaction (Bagchi et al. 1989 ). On the basis of similarities that we observe between activation of E2F and E4F, we have investigated the role of phosphorylation in E4F activation. A preparation of purified E4F was incubated with agarose-bound calf intestinal phosphatase and then assayed for E4F activity. As seen in Figure  4A , incubation with phosphatase rapidly inactivated E4F binding activity. In addition, the inactivation of E4F activity by phosphatase was not an irreversible event. An extract prepared from adenovirus-infected cells and fractionated by heparin agarose chromatography to remove active E4F was capable of reactivating E4F activity upon incubation with the phosphatase-treated factor (Fig. 4B) . In contrast, a similarly fractionated extract prepared from d/312-(E1A-) infected cells did not restore E4F activity, and incubation of either of these heparin agarosefractionated extracts alone did not result in E4F activity.
Competition with an E4F-specific oligonucleotide demonstrated that this reactivated binding activity possessed the proper specificity, as evidenced by the loss of the characteristic E4F complex (Fig. 4C) . Although a few of the faster-migrating complexes also were competed, the relationship of these to E4F is not clear; they appear to derive from the heparin flowthrough fractions and are equivalent in Ad5 and d1312 extracts.
Because we used an E4F preparation for the experiment of Figure 4B that had been purified through an E4F DNA affinity column, thus selecting for active E4F, we conclude that the E4F activity generated during the incubation must have derived from protein that was previously active and then inactivated as a result of phosphatase treatment. The reactivation is ATP-dependent, although this only becomes clear when the activity is partially purified, presumably due to ATP levels in the crude extracts (data not shown). Consistent with a phosphorylation-dependent activation of E4F DNA-binding activity is the labeling of a 50-kD polypeptide with [7-32P] ATP during the activation that co-purifies with E4F binding activity on the CM-Sepharose column and is retained selectively on an E4F affinity column (Fig.  4D) . On the basis of results shown in Figure 4 , we conclude that E4F DNA-binding activity requires phosphorylation, that an activation of E4F DNA-binding activity can be mediated in cell-flee extracts, and that this activation likely reflects the normal E1A-dependent in vivo process.
Discussion
The E4F factor interacts with sequences in the E4 promoter that have been shown to be critical for E4 transcription and that can confer inducibility to a heterologous promoter (Gilardi and Perricaudet 1984; Raychaudhuri et al. 1987} . Furthermore, there is a close correlation between the increase in E4F binding activity in extracts of infected cells and the E1A-induced transcription of the E4 promoter (Nevins et al. 1979; Raychaudhuri et al. 1987 ). Given our observations that the purified E4F factor is also able to stimulate . E4F binding activity is regulated by phosphorylation. {A) Inactivation of E4F with phosphatase. Affinity-purified E4F was incubated with or without phosphatase and then assayed for binding activity by a gel retardation assay as described in Materials and methods. {B) Reactivation of E4F activity. Gel retardation assays of E4F incubated without phosphatase {E4FI or with phosphatase {+ phosphatase) are shown in the two lefthand lanes. The phosphatase-treated E4F was then incubated with heparin flowthrough fractions from Ad5-infected cells or d/312-irtfected cells, as described in Materials and methods, and then assayed for E4F activity (two middle lanes}. Finally, assay of the two heparin fiowthrough fractions incubated alone is shown in the two righthand lanes. (C} Phosphatase-treated E4F after reactivation with the heparin flowthrough fraction from the Ad5 extract was assayed in the presence {lane +} or absence {lane -) of the E4F-specific oligonucleotide as described in Fig. 3 .
(D) Phosphatase-inactivated E4F was incubated with the heparin flowthrough fraction from Ad5-infected cells in the presence of [7-a~P]ATP as described in Materials and methods.
The products were then fractionated on a CM-Sepharose column, and the fractions were assayed for E4F activity. Those fractions containing E4F activity were pooled and chromatographed on an E4F DNA affinity column. After washing at 0.4 M KC1, a 0.7 lvt eluate was collected, a~P-Labeled proteins in the CM-Sepharose fractions and the 0.7 M affinity column eluate were analyzed by SDS gel electrophoresis and autoradiography.
E4 transcription in vitro, we suggest that the E4F factor is a mediator of E1A-dependent stimulation of E4 transcription within the infected cell. Yee et al. 19891 . This is not t o s a y that ATF might not participate in E1A control, possibly through the formation of a complex with EIA (Lillie and Green 1989) , but there is as yet no direct evidence for such. Whether E4F and ATF are related proteins {part of a gene family), or even different forms of the same gene product, is not clear and will only be defined by the isolation of the genes encoding these factors. There is yet a third activity that recognizes the E4F site, termed EivF {Cortes et al. 1988}, but this factor is clearly distinct from E4F on the basis of physical properties. Despite this complexity, the various binding activities are distinct, and, at the moment, the characteristics of the E4F factor more closely correlate with a role in E1A-dependent activation of E4 transcription. Recent studies demonstrate that the target in the hsp70 promoter {Simon et al. 1988), as well as the E1B promoter (Wu et al. 1987) , for EIA-dependent stimulation is the TATA element. Furthermore, the TFIIIC factor is involved in activation of polymerase III transcription (Berger and Folk 19851 Gaynor et al. 19851 Hoeffler and Roeder 19851 Yoshinaga et al. 19861 Hoeffler et al. 1988} , indicating that E1A-dependent control of transcription is a complex process whereby multiple proteins are activated in some manner by E1A. The activation studies described here suggest that ahhough EIA-dependent trans-activation must involve the acti- 
DNA-binding activity of E4F
part of the mechanism. Although we cannot comment on the control of TFIIIC or the TATA factor, the comparison of E4F and E2F suggests a common basis for control involving phosphorylation. As demonstrated here and elsewhere, both factors bind to critical sequences in the respective promoters; the DNA-binding activity of both factors is induced in virus infections and with kinetics coincident with transcription of the respective genes; and the DNA-binding activity of both factors is regulated during F9 cell differentiation in a manner consistent with control by a cellular E1A activity. Finally, the results presented in this paper and elsewhere (Bagchi et al. 1989 )demonstrate that the DNA-binding activity of both factors is sensitive to phosphatase treatment and that both factors can be reactivated by incubation with extracts prepared from virus-infected cells. We suggest that the DNA-binding activity of the E2F and E4F transcription factors is regulated by a phosphorylation/dephosphorylation mechanism involving a specific kinase and phosphatase. We envision that the equilibrium between active and inactive factor varies depending on the cellular environment, and that as a result of virus infection it is shifted markedly in favor of the active moleGules.
From in vivo experiments it is clear that the 289-amino-acid EIA protein is part of this process, although it is impossible to determine at this time the actual role of the EIA protein in the activation. Indeed, we view a direct role for E1A in the kinase reaction as unlikely because all known kinases possess a conserved sequence at the ATP binding site (Hanks et al. 1988) , whereas the E1A protein is devoid of any such sequence. Rather, EIA may serve as an effector molecule for an existing kinase or may in some manner initiate a cascade of events leading to the eventual activation of a kinase. The precise role of EIA in this process as well as the complexity of the activities involved will likely only be determined by further purification. Regardless of the number of activities involved, it does appear that the trans-activation process may involve a common phosphorylation event of the E2F and E4F factors. Certainly, a role for phosphorylation in the control of transcription factor activity is not unprecedented. Previous studies have shown that a number of cellular transcription factors, including the cAMP regulatory element binding protein (CREB) (Montminy and Bilezikjian 1987) , the serum regulatory factor (SRF) (Prywes et al. 1988) , the heat shock transcription factor (HSTF) (Sorger et al. 1987; Sorger and Pelham 1988) , and possibly the polymerase III TFIIIC transcription factor (Hoeffler et al. 1988 ) are regulated by phosphorylation. In the case of CREB, phosphorylation by distinct kinases may control different properties of the protein, including DNA-binding and transcription activity (Yamamoto et al. 1988) . Of interest in the E1A system is the fact that at least two different transcription factors may be commonly recognized and activated by phosphorylation. Furthermore, although it is only speculative at the present time, it remains possible that the TFIIIC and TATA factors are regulated similarly. One could imagine that each of these factors possesses a common domain recognized by the kinase involved in the activation. As a result, multiple factors could be activated coordinately and thus direct the transcription activation of a group of diverse genes.
Materials and methods
Cells and virus
The procedures for the growth of HeLa cells, F9 cells, and adenovirus have been described (Nevins 1980; Imperiale et al. 1984) .
E4F purification
One gram of HeLa whole-cell extract (from 15 liters of AdS-infected HeLa cells), prepared as described previously (Raychaudhuri et al. 1987) , was fractionated on a 25-ml heparin-agarose (Sigma) column. After loading, the column was washed successively with 100 ml of buffer A [20 mM HEPES (pH 7.9), 0.2 DTT, 0.2 rnM EDTA, 0.5 mM PMSF, and 10% glycerol] + 0.1 M KC1 and 100 ml of buffer A + 0.25 M KC1. The column was then eluted with a 250-ml, 0.25 M to 0.75 M KG1 gradient in buffer A. Fractions containing the majority of E4F activity were pooled (60 rag) and diluted with 3 volumes of buffer B [20 mM Tris-HC1 (pH 7.5), 0.2 mM DTT, 0.5 mM PMSF, and 10% glycerol] containing no KC1 and applied to a 15-ml DEAE-Sephadex column previously equilibrated with buffer B + 0.1 M KC1. The column was eluted with a 150-ml KC1 gradient from 0.1 M to 0.4 M. E4F activity (6 mg protein) from the DEAE-Sephadex column was diluted with 1 volume of buffer B containing no KC1 and chromatographed on a 5-ml CM-Sepharose column, equilibrated with buffer B + 0.1 M KC1. The column was eluted with a 50-ml linear gradient from 0.1 M KC1 to 0.4 M KC1 and 1.2-ml fractions were collected. E4F activity eluted from this column after elution of the bulk of the applied proteins. The CM-Sepharose-purified E4F (0.4 mg protein) was purified further by chromatography on a 1-ml DNA-Sepharose column, containing multimers of the E4F binding site (sequences between -43 and -54 of the E4 promoter) prepared as described (Kadonaga and Tjian 1986) . The flowthrough material was loaded for a second time, and then the column was washed successively with 10 ml of buffer C [20 rnM Tris-HC1 (pH 7.5), 5 mM MgC12, 0.1 ~ DTT, 20% glycerol, and 0.1% NP-40] containing 0.25 M KC1 and 10 ml of buffer C containing 0.4 M KC1, and finally with 5 ml of buffer C containing 0.7 M KC1. Aliquots of the loading material (CM-Sepharose pool), the flowthrough of the affinity column, and fractions from each of the washes were assayed.
E4F binding assays
Binding assays contained 20 mlvi HEPES (pH 7.6), 1 mlvl MgC1, 1 rnM EDTA, and 40-60 ~ KC1, 0.5 ng of 3'-end-labeled probe, 0.5-3 ~g of poly[d(I-C)], poly[d(I-C)] (Pharmacia), and 1-3 ~1 of column fractions in a total volume of 30 ~1. Each was incubated for 20 min at room temperature; then 5 ~1 of 20% Ficoll was added and 6 ~1 was analyzed in a 4% acrylamide gel, as described previously (Raychaudhuri et al. 1987) .
DNase footprint assays
A 0.2-ng amount of the EcoRI-HindIII fragment of the plasmid pE4 (Raychaudhuri et al. 1987) , 3'-end-labeled at the EcoRI site (coding strand) or at the HindIII site (noncoding strand)were incubated with aliquots of the 0.7 M eluate from the DNA affinity column or the same volume of 0.7 M elution buffer. At the end of the incubation, an equal volume (30 ~1) of a solution containing 10 rnM MgC12 and 5 rnM CaC12 was added followed by the addition of 2 ng of freshly diluted DNase I (Worthington). The digestions were carried out for 60 sec. The reaction was stopped by adding 140 ~1 of stop buffer (TE + 0.1 M NaC1 + 0.2% SDS), 200 ~1 of phenol, and 200 ~1 of CHCla. The aqueous layer was extracted further with 200 ~1 CHCla and ethanol-precipitated in the presence of 5 ~g tRNA. The precipitates were dissolved and analyzed in a 6% acrylamide sequencing gel.
Renaturation of E4F activity
Renaturation of E4F was carried out following the procedures described by Hager and Burgess {1980)with slight modification. E4F (25 ~g)purified through the CM-Sepharose step was fractionated by electrophoresis in a 10% acrylamide SDS slab gel. Proteins from each 2-mm slice were eluted for 2 hr. Acetone precipitates of each sample were dissolved in 25 ~1 of 6 M guanadine hydrochloride in binding buffer and allowed to stand for 10 rain. The samples were then diluted with 1 volume of binding buffer and filtered through a 0.4-ml Bio-Gel P10 column to remove guanidine-hydrochloride. After 1 hr of renaturation, 2.5 ~1 of each sample (5% of the total)was assayed for E4F activity by gel retardation assays.
In vitro transcription
A 0.15-~g amount of SphI-digested pE4a or 0.15-~g amount of HindIII-digested pML were preincubated with 25 ~1 of nuclear extract and 5 ~1 of the designated column fraction in a final volume of 50 ~1 with buffer containing 12 mM HEPES (pH 7.9), 0.3 mM DTT, 0.12 mM EDTA, and 10 mM MgC12 at room temperature for 15 rain. The final KC1 concentration in the reaction mixes was a sum of 50 mM KC1 and that contributed by 5 ~1 of the column fraction. At the end of the preincubation, nucleotides were added to a final concentration of: 0.5 rnM ATP, 0.5 mM UTP, 0.5 mM CTP, and 0.05 mM [~/-32p]GTP (10 ~Ci). Incubation was continued for another 45 min at 30°C and then treated with 2.5 units of RNase-free DNase (BoehringerMannheim) for 5 min at 30°C. RNA was extracted with phenol, ethanol-precipitated, and analyzed in a 6% acrylamide-urea gel.
Phosphatase digestion
DNA-affinity column-purified E4F fraction was incubated with agarose-bound calf intestinal phosphatase (Sigma, 12 U/ml)for 10 rain at room temperature in 50 mM Tris-HC1 {pH 9.0), 0.2 M KC1, 1 mM MgC12, 0.1 rnM ZnCI~, and 10% glycerol. The phosphatase was removed by a brief, 30-see centrifugation at 5000 rpm in a microfuge. The supernatant was centrifuged again at 4°C for 10 min at 10,000 rpm, and then 5 ~1 was used to assay for E4F.
Reactivation assays
Whole-cell extracts prepared from Ad5-infected or d/312-infected differentiated F9 cells were fractionated by heparinagarose chromatography. In each case, 7 ~1 of the heparin flowthrough fraction was incubated with 5 ~1 of phosphataseinactivated E4F (supematant after centrifugation of the agarose-bound phosphatase). Incubation was in a 30-~1 reaction volume at 30°C for 60 min in the presence of 3 ~g of poly[d(I-CI], 0.25 ng of specific DNA probe, 5 mM MgC1, 1 mM ATP, 20 mM Tris-HC1 (pH 7.5), and 100 mM KC1. E4F activity was then assayed as described before.
Phosphorylation of E4F
A 60-~g amount of phosphatase-inactivated E4F protein {puri-fied through CM-Sepharose chromatography)was first incubated with 0.5 mg of a 0.1 M heparin-agarose fraction obtained from wild-type Ad5-infected dF9 whole-cell extract in the presence of 5 ~M [~/-32p]ATP {20 ~Ci), 10 MgC12, 20 mM Tris-HC1 (pH 7.5J, 100 mM KC1, and 5 mM sodium fluoride for 1 hr at room temperature. The incubation mixture was then fractionated on a 1.5-ml CM-Sepharose column as described for the purification of E4F, except that the total volume of the gradient was 15 ml, and 0.5-ml fractions were collected. Aliquots (10 ~1) of the designated fractions were assayed for E4F activity and a2P-labeled proteins from the designated fractions (50 ¢1)were analyzed in 10% SDS-PAGE followed by autoradiography. Fractions 12-20 were pooled and directly applied to a 1-ml E4F-specific DNA affinity column. The 0.7 M eluate was analyzed in 10% SDS-PAGE followed by autoradiography for a2P-labeled E4F polypeptide.
